• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Neuraminidase inhibitor susceptibility and evolutionary analysis of human influenza B isolates from three Asian countries during 2012-2015

tetano

Editor, Senior Moderator
Infect Genet Evol. 2018 Apr 14. pii: S1567-1348(18)30194-1. doi: 10.1016/j.meegid.2018.04.016. [Epub ahead of print]
[h=1]Neuraminidase inhibitor susceptibility and evolutionary analysis of human influenza B isolates from three Asian countries during 2012-2015.[/h] Hibino A[SUP]1[/SUP], Massaad E[SUP]2[/SUP], Kondo H[SUP]3[/SUP], Saito R[SUP]4[/SUP], Odagiri T[SUP]3[/SUP], Takemae N[SUP]5[/SUP], Tsunekuni R[SUP]5[/SUP], Saito T[SUP]5[/SUP]; Japanese Influenza Collaborative Study Group, Kyaw Y[SUP]6[/SUP], Lin N[SUP]7[/SUP], Myint YY[SUP]8[/SUP], Tin HH[SUP]8[/SUP], Le Khanh Hang N[SUP]9[/SUP], Mai LQ[SUP]9[/SUP], Yagami R[SUP]10[/SUP], Shobugawa Y[SUP]10[/SUP], Lam T[SUP]11[/SUP], Zaraket H[SUP]12[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Influenza B viruses of both the Yamagata and the Victoria lineages are implicated in a large proportion of the morbidity and mortality associated with influenza outbreaks. In this study, we characterized the full genomes of 53 influenza B viruses isolated during 2012-2015 in three Asian countries: Japan, Myanmar, and Vietnam. Analysis of the hemagglutinin (HA) genes revealed co-circulation of both the Yamagata and Victoria lineages within the same season in these countries. Our analysis revealed, that a large proportion of viruses circulating during 2013-2014 in Japan and Vietnam were mismatched to the vaccine supporting the rationale for using quadrivalent vaccines. Molecular analysis of the neuraminidase (NA) genes did not reveal any of the previously reported substitutions associated with reduced susceptibility to neuraminidase inhibitors (NAIs). However, one isolate from Nagasaki displayed reduced inhibition by NAIs, associated with an NA-M426I substitution (N2-numbering). Phylogenetic analysis of the eight genome segments identified a 6 + 2 reassortant strain belonging to the Victoria lineage that circulated in Japan during the 2013-2014 season. This strain appears to have evolved from a descendent of a B/Brisbane/60/2008-like strain in an intra-lineage reassortment event involving the nucleoprotein (NP) and nonstructural (NS) genes. Therefore, influenza B strains circulating worldwide continue to evolve via complex reassortment events, which contribute to their survival and the emergence of new strains. These findings highlight the need for ongoing genome-wide studies of circulating viruses and assessing the implications of these evolutionary events on the vaccines.


[h=4]KEYWORDS:[/h] Asia; Influenza B; Neuraminidase inhibitors; Reassortment; Reduced susceptibility

PMID: 29665435 DOI: 10.1016/j.meegid.2018.04.016
 
Back
Top Bottom